Hosted on MSN1mon
Vanda and AnaptysBio link for generalised pustular psoriasis therapy
"We are excited to add imsidolimab to Vanda's product portfolio for rare orphan disorders, as well as explore the potential of this IL-36 signal regulator in the treatment of additional ...
Investing1mon
Vanda Pharmaceuticals develops ASO therapy for rare disease
WASHINGTON - Vanda Pharmaceuticals Inc. (NASDAQ ... VCA-894A, targeting a rare genetic mutation associated with Charcot-Marie-Tooth disease Type 2S (CMT2S). According to InvestingPro analysis ...
Investing1mon
Vanda Pharmaceuticals develops ASO therapy for rare disease
WASHINGTON - Vanda Pharmaceuticals Inc. (NASDAQ ... therapeutic, VCA-894A, targeting a rare genetic mutation associated with Charcot-Marie-Tooth disease Type 2S (CMT2S). According to InvestingPro ...